Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Luke Moore and Paul Randell.
Luke Moore
Connection Strength
0.919
Paul Randell
  1. Optimising the initial investigation of suspected cases of SARS-CoV-2 reinfection. Travel Med Infect Dis. 2021 Jul-Aug; 42:102078.
    View in: PubMed
    Score: 0.236
  2. Structured serological testing is an essential component to investigating SARS-CoV-2 reinfection. Lancet Infect Dis. 2021 05; 21(5):598-599.
    View in: PubMed
    Score: 0.231
  3. Non-invasive saliva specimens for the diagnosis of COVID-19: caution in mild outpatient cohorts with low prevalence. Clin Microbiol Infect. 2020 Dec; 26(12):1711-1713.
    View in: PubMed
    Score: 0.223
  4. Real-world evaluation of COVID-19 lateral flow device (LFD) mass-testing in healthcare workers at a London hospital; a prospective cohort analysis. J Infect. 2021 10; 83(4):452-457.
    View in: PubMed
    Score: 0.060
  5. Detection of SARS-CoV-2 Antibodies in Kidney Transplant Recipients. J Am Soc Nephrol. 2020 12; 31(12):2753-2756.
    View in: PubMed
    Score: 0.057
  6. Assessing a novel, lab-free, point-of-care test for SARS-CoV-2 (CovidNudge): a diagnostic accuracy study. Lancet Microbe. 2020 Nov; 1(7):e300-e307.
    View in: PubMed
    Score: 0.056
  7. Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study. Lancet Respir Med. 2020 09; 8(9):885-894.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.